Publications from the Centre for Immuno-Oncology
Closing the equity gap in the treatment of HIV-2 infection.
Rowland-Jones S. and Gea-Mallorquí E., (2024), The lancet. HIV, 11, e347 - e349
Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1.
Alrubayyi A. et al, (2023), Scientific reports, 13
Intracellular trafficking of HLA-E and its regulation.
He W. et al, (2023), The Journal of experimental medicine, 220
The Preprint Club: A blueprint for community-based peer review: A blueprint for community-based peer review.
Richter FC. et al, (2023), EMBO reports, 24
Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles.
Touizer E. et al, (2023), iScience, 26
DC-targeting lentivectors for cancer immunotherapy.
Gea-Mallorquí E. and Rowland-Jones S., (2023), Immunotherapy advances, 3
Dynamics of antigen retention by follicular dendritic cells.
Ruffin N. and Gea-Mallorquí E., (2022), Nature reviews. Immunology, 22
Comparative immunology reveals different flavours of cGAS.
Charlton B. and Gea-Mallorquí E., (2022), Nature reviews. Immunology, 22
Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50.
Xie J. et al, (2022), Nature communications, 13
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV.
Alrubayyi A. et al, (2021), Nature communications, 12
Clonotypic architecture of a Gag-specific CD8+ T-cell response in chronic human HIV-2 infection.
Moysi E. et al, (2021), European journal of immunology, 51, 2485 - 2500
Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology.
Codd AS. et al, (2021), Oxford open immunology, 2